Switzerland drug approvals | Swissmedic news | Blogs | 2023 | iPharmaCenter
- ipharmaservices
- Jul 10, 2023
- 0 min read
top of page
Recent Posts
See AllThe European Commission has issued marketing authorization for once-daily oral semaglutide 25 mg tablets, marketed under the Wegovy brand, for the management of obesity and weight-associated comorbidi
The European Commission (EC) has granted tumor-agnostic approval for Enhertu (trastuzumab deruxtecan) to treat adult patients presenting with unresectable or metastatic HER2-positive solid tumors. Bec
In the first quarter of 2026, statutory health insurance funds collected about €94.4 billion in revenues and spent roughly €93.1 billion on benefits and administration. Expenditure rose by around 7.7
bottom of page
Comments